 1  5 
0.009 ± 0.001 pmol (mean ± SD), 24 hpf = 0.012 ± 0.002 pmol, 48 hpf = 0.034 ± 0.005 2 4 3 pmol, 72 hpf = 0.038 ± 0.002 pmol, 96 hpf = 0.050 ± 0.003 pmol). As with [ 3 H]EE2, there 2 4 4 was no significant difference in uptake when comparing uptake of embryos when 2 4 5 starting treatment at 6 vs. 24 hpf (one-way ANOVA, p = 0.6854) or 48 vs. 72 hpf (p = 2 4 6 0.5343), but all other comparisons were significantly increased when starting treatment 2 4 7 in older versus younger embryos (Table S3 ). Table S3 ; 6 hpf treatment = 0.18 ± 0.040 pmol (mean ± SD), 24 hpf = 0.31 ± 0.082 2 5 2 pmol, 48 hpf = 0.54 ± 0.11 pmol, 72 hpf = 0.50 ± 0.070 pmol, 96 hpf = 0.73 ± 0.057 2 5 3 pmol). No significant change was seen when comparing treatment start at 6 vs. 24 hpf 2 5 4 (one-way ANOVA, p = 0.2794), 24 vs. 72 hpf (p = 0.0742), 48 vs. 72 hpf (p = 0.9649), or 2 5 5 48 vs. 96 hpf (p = 0.0683), but all other comparisons were significantly increased in 2 5 6 older versus younger embryos (Table S3 ). [ 3 H]BPA percent uptake increased 7.5-fold 2 5 7 when starting treatment at 96 hpf vs. 6 hpf ( Fig. 2C , Table S3 ; 6 hpf treatment = 0.037 ± 2 5 8 0.006 pmol (mean ± SD), 24 hpf = 0.053 ± 0.006 pmol, 48 hpf = 0.18 ± 0.010 pmol, 72 2 5 9 hpf = 0.19 ± 0.012 pmol, 96 hpf = 0.277 ± 0.031 pmol). Uptake was significantly 2 6 0 increased when treating older versus younger embryos for every developmental stage 2 6 1 (Table S3 ) except when comparing 6 vs. 24 hpf (one-way ANOVA, p = 0.6975) and 48 2 6 2 vs. 72 hpf embryos (p = 0.9833). When increasing exposure duration to 24 hours, [ 3 H]EE2 mean pmol uptake of 2 6 5 beginning exposure at 96 hpf was 3.6-fold higher than beginning at 6 hpf, consistent 2 6 6 with 1 hour exposure. In contrast, pmol absorption plateaued following exposure 2 6 7 beginning at 72 hpf or older ( Fig. 2B , Table S4 ; 6 hpf treatment = 0.19 ± 0.008 pmol 2 6 8 (mean ± SD), 24 hpf = 0.22 ± 0.011 pmol, 48 hpf = 0.36 ± 0.062 pmol, 72 hpf = 0.66 ± 2 6 9 0.077 pmol, 96 hpf = 0.68 ± 0.040 pmol). There was a significantly higher uptake in 2 7 0 older versus younger embryos at each developmental stage (Table S4) comparing exposures beginning at 6 vs. 24 hpf (one-way ANOVA, p = 0.9118) and 72 2 7 2 vs. 96 hpf (p = 0.9857). There was a relatively smaller increase in [ 3 H]BPA pmol uptake with developmental 2 7 5 stage compared to 1 hour exposure, with a 3.8-fold increase when exposure began at 2 7 6 96 hpf compared to 6 hpf. This increase plateaued when exposure began at 48 hpf and Table S4 ; 6 hpf treatment = 0.10 ± 0.014 pmol (mean ± SD), 24 hpf = 2 7 8 0.17 ± 0.006 pmol, 48 hpf = 0.40 ± 0.070 pmol, 72 hpf = 0.53 ± 0.025 pmol, 96 hpf = 2 7 9 0.38 ± 0.091 pmol). There was a significantly higher uptake when comparing exposure 2 8 0 starting at 48 vs. 96 hpf (one-way ANOVA, p = 0.0448). For each other comparison, 2 8 1 there was a significantly higher uptake when starting exposure in older versus younger 2 8 2 embryos (Table S4 ) except when comparing 6 vs. 24 hpf (one-way ANOVA, p = 2 8 3 0.5497), 48 vs. 72 hpf (p = 0.0688), and 48 vs. 96 hpf (p = 0.9985), which had no 2 8 4 significant change. Percent uptake following 24 hour exposure was similarly increased with increasing 2 8 7 developmental stage for both compounds. Mean percent [ 3 H]EE2 uptake was increased 2 8 8 by 3.9-fold when starting treatment in 96 hpf versus 6 hpf embryos with a plateau ≥ 72 2 8 9 hpf (Fig. 2B , Table S4 ; 6 hpf treatment = 1.49 ± 0.051% (mean ± SD), 24 hpf = 1.65 ± 2 9 0 0.096%, 48 hpf = 2.88 ± 0.4%, 72 hpf = 5.82 ± 0.75%, 96 hpf = 5.81 ± 0.44%).
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Comparisons between exposure start at older and younger developmental stages 2 9 2 showed significantly higher uptake when starting exposure at older stages (Table S4) 2 9 3 except when comparing 6 vs. 24 hpf (one-way ANOVA, p = 0.9897) and 72 vs. 96 hpf (p 2 9 4 > 0.9999). [ 3 H]BPA percent uptake increased 5.1-fold in 96 hpf versus 6 hpf embryos 2 9 5 with a plateau in uptake ≥ 48-72 hpf ( Fig. 2D , Table S4 ; 6 hpf treatment = 0.53 ± 2 9 6 0.081% (mean ± SD), 24 hpf = 0.94 ± 0.10%, 48 hpf = 2.04 ± 0.080%, 72 hpf = 3.38 ± 2 9 7 0.21%, 96 hpf = 2.70 ± 0.75%). Uptake was significantly increased when starting 2 9 8 treatment in older versus younger embryos (Table S4 ) except when comparing 6 vs. 24 2 9 9 hpf (one-way ANOVA, p = 0.6223), 48 vs. 96 hpf (0.2288), and 72 vs. 96 hpf (p = 3 0 0 0.2076). When comparing percent [ 3 H]EE2 uptake following 1 hour exposure, there was a 3 1 1 modest increase relative to [ 3 H]E2 at embryos 6-48 hpf ( Fig. 3C , Table S5 ; fold-change 3 1 2 at 6 hpf = 1.72 ± 0.39 (mean ± SD), 24 hpf = 1.27 ± 0.33, 48 hpf = 1.41 ± 0.30, 72 hpf = 3 1 3 0.84 ± 0.12, 96 hpf = 0.81 ± 0.067), but no developmental stage had a statistically 3 1 4 significant change (Table S5 ). When comparing [ 3 H]BPA uptake to [ 3 H]E2 uptake, there Table S5 ; one-way ANOVA; fold-change at 6 hpf = 0.36 ± 0.056, p = 0.0001; 24 hpf = 3 1 7 0.22 ± 0.023, p = 0.0001; 48 hpf = 0.47 ± 0.030, p = 0.0005; 72 hpf = 0.31 ± 0.023, p = 3 1 8 0.0001; 96 hpf = 0.31 ± 0.031, p = 0.0001). With 24 hour exposure, we observed a statistically significant increase in [ 3 H]EE2 3 2 1 percent uptake relative to [ 3 H]E2 uptake in the 6 hpf group (one-way ANOVA, p = Table S5 ; fold-change at 6 hpf = 1.79 ± 0.062, 24 hpf = 0.89 ± 0.050, 48 hpf = 0.75 ± 3 2 4 0.11, 72 hpf = 0.79 ± 0.10, 96 hpf = 1.06 ± 0.081). Results with 24 hour exposure with decrease in uptake at each developmental stage, though the decrease at 6 hpf was not example, if 24 hpf embryos are exposed to E2 for 24 hours, we estimate that half the E2 4 0 2 that is taken up by the embryo will be deposited in the yolk. Extrapolating these results 4 0 3 to EE2, which exhibited 1.6% uptake into the entire embryo, we predict that 0.8% of 4 0 4 exogenous EE2 will be deposited in the yolk. This suggests that higher concentrations of the embryo. Acute treatments at these stages may also have longer term effects 4 0 7 since EE2 absorbed into the yolk is available to diffuse into the embryo as it develops. The similar uptake results obtained with E2 and EE2 support the hypothesis that 4 0 9 steroidal estrogens are absorbed equivalently by zebrafish embryos. Consequently, we 4 1 0 speculate that the E2 and EE2 uptake properties are broadly applicable to any steroidal 4 1 1 EED. Uptake of specific compounds can be confirmed using our isotopic assay. Finally, 4 1 2 the similarity in E2 uptake, as an endogenous estrogen, and EE2 uptake, as a synthetic 4 1 3 estrogen, suggests that endogenous estradiol levels do not limit E2 uptake at the levels 4 1 4 present in zebrafish embryos and larvae. This suggests there are low levels of E2 4 1 5 present in the embryo, insufficient to affect passive diffusion gradients, or that there is 4 1 6 some transport mechanism that is able to augment E2 uptake in embryos. Comparing BPA uptake to E2 uptake can further inform future studies using non-1 efficacy. Therefore, comparisons of the effects of such compounds may require 1 mg, this value is nearly 50-fold lower than the uptake we observed in 6 hpf embryos 4 5 5
following 24 hour 5 nM exposure, though this discrepancy could be attributed to the 30- Comparison to uptake studies using chromatography and mass spectrometry 4 6 1
In one study using high-performance liquid chromatography coupled to mass 4 6 2 spectrometry (HPLC-MS) to measure BPA uptake into zebrafish embryos, there was a 4 6 3 0.02 μ g/kg uptake observed following 1 nM exposure from 8-58 hpf (Saili et al., 2012) . effluxed by Abcb4. We found, however, that co-treatment with the Pg-p inhibitor CsA 5 0 0 modestly decreased [ 3 H]E2 uptake, and that PBDE-100 had no effect on uptake. One Lawson, N.D., Goessling, W., North, T.E., 2014. Estrogen defines the dorsal-ventral 5 7 5 limit of VEGF regulation to specify the location of the hemogenic endothelial niche. Dev Cell 29, 437-453. Christen, V., Fent, K., 2014. Tissue-, sex-and development-specific transcription Huang, L., Hoffman, T., Vore, M., 1998. Adenosine triphosphate-dependent transport of compared to E2 in 6-96 hpf zebrafish exposed to 5 (unpaired Student's t-test, ns not significant, p≥0.05). (D) Embryos at 72 hpf were exposed to 5 nM [ 3 H]E2 
